BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11372759)

  • 1. A functional role of mitogen-activated protein kinases, erk1 and erk2, in the differentiation of a human leukemia cell line, UT-7/GM: a possible key factor for cell fate determination toward erythroid and megakaryocytic lineages.
    Uchida M; Kirito K; Shimizu R; Miura Y; Ozawa K; Komatsu N
    Int J Hematol; 2001 Jan; 73(1):78-83. PubMed ID: 11372759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of both erythroid and megakaryocytic differentiation of a human leukemia cell line, UT-7.
    Miura Y; Kirito K; Komatsu N
    Acta Haematol; 1998; 99(3):180-4. PubMed ID: 9587401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro development of erythroid and megakaryocytic cells from a UT-7 subline, UT-7/GM.
    Komatsu N; Kirito K; Shimizu R; Kunitama M; Yamada M; Uchida M; Takatoku M; Eguchi M; Miura Y
    Blood; 1997 Jun; 89(11):4021-33. PubMed ID: 9166841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO.
    Komatsu N; Kunitama M; Yamada M; Hagiwara T; Kato T; Miyazaki H; Eguchi M; Yamamoto M; Miura Y
    Blood; 1996 Jun; 87(11):4552-60. PubMed ID: 8639823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombopoietin induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in a human thrombopoietin-dependent cell line.
    Yamada M; Komatsu N; Okada K; Kato T; Miyazaki H; Miura Y
    Biochem Biophys Res Commun; 1995 Dec; 217(1):230-7. PubMed ID: 8526916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of erythroid differentiation and induction of megakaryocytic differentiation by thrombopoietin are regulated by two different mechanisms in TPO-dependent UT-7/c-mpl and TF-1/c-mpl cell lines.
    Goncalves F; Lacout C; Féger F; Cohen-Solal K; Guichard J; Cramer E; Vainchenker W; Duménil D
    Leukemia; 1998 Sep; 12(9):1355-66. PubMed ID: 9737683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta1 interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells.
    Kalina U; Koschmieder S; Hofmann WK; Wagner S; Kauschat D; Hoelzer D; Ottmann OG
    Exp Hematol; 2001 May; 29(5):602-8. PubMed ID: 11376873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of thrombopoietin-induced activation of ERK for megakaryocyte differentiation and of p38 for erythroid differentiation.
    Miyazaki R; Ogata H; Kobayashi Y
    Ann Hematol; 2001 May; 80(5):284-91. PubMed ID: 11446731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of extracellular signal-regulated kinases ERK1 and ERK2 induces Bcl-xL up-regulation via inhibition of caspase activities in erythropoietin signaling.
    Mori M; Uchida M; Watanabe T; Kirito K; Hatake K; Ozawa K; Komatsu N
    J Cell Physiol; 2003 May; 195(2):290-7. PubMed ID: 12652655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EVI1 is expressed in megakaryocyte cell lineage and enforced expression of EVI1 in UT-7/GM cells induces megakaryocyte differentiation.
    Shimizu S; Nagasawa T; Katoh O; Komatsu N; Yokota J; Morishita K
    Biochem Biophys Res Commun; 2002 Apr; 292(3):609-16. PubMed ID: 11922610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Raf/ERK1/2 MAP kinase pathway is involved in GM-CSF-induced proliferation and survival but not in erythropoietin-induced differentiation of TF-1 cells.
    Kolonics A; Apáti A ; Jánossy J; Brózik A; Gáti R; Schaefer A; Magócsi M
    Cell Signal; 2001 Oct; 13(10):743-54. PubMed ID: 11602185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors.
    Zhang J; Lodish HF
    Blood; 2004 Sep; 104(6):1679-87. PubMed ID: 15166036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A induces erythroid differentiation of K562 cells through p38 MAPK and ERK pathways.
    Sawafuji K; Miyakawa Y; Kizaki M; Ikeda Y
    Am J Hematol; 2003 Jan; 72(1):67-9. PubMed ID: 12508271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiation.
    Madoiwa S; Komatsu N; Mimuro J; Kimura K; Matsuda M; Sakata Y
    Blood; 1999 Jul; 94(2):475-82. PubMed ID: 10397715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TEL/ETV6 accelerates erythroid differentiation and inhibits megakaryocytic maturation in a human leukemia cell line UT-7/GM.
    Takahashi W; Sasaki K; Kvomatsu N; Mitani K
    Cancer Sci; 2005 Jun; 96(6):340-8. PubMed ID: 15958056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel function of Stat1 and Stat3 proteins in erythropoietin-induced erythroid differentiation of a human leukemia cell line.
    Kirito K; Uchida M; Takatoku M; Nakajima K; Hirano T; Miura Y; Komatsu N
    Blood; 1998 Jul; 92(2):462-71. PubMed ID: 9657745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombopoietin supports the continuous growth of cytokine-dependent human leukemia cell lines.
    Drexler HG; Zaborski M; Quentmeier H
    Leukemia; 1997 Apr; 11(4):541-51. PubMed ID: 9096695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin induction of tissue inhibitors of metalloproteinase-1 expression and secretion is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways.
    Kadri Z; Petitfrère E; Boudot C; Freyssinier JM; Fichelson S; Mayeux P; Emonard H; Hornebeck W; Haye B; Billat C
    Cell Growth Differ; 2000 Nov; 11(11):573-80. PubMed ID: 11095246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy.
    Tong Z; Singh G; Rainbow AJ
    Cancer Res; 2002 Oct; 62(19):5528-35. PubMed ID: 12359764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.